Israel-based Check-Cap enrolled its first patient in a multi-center study as it works to earn a CE Mark for its C-Scan system. Here’s what you should know. 1. The C-Scan system uses ultra-low dose ...
ISFIYA, Israel, July 9, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the ...
The FDA granted conditional approval of medical diagnostic company Check-Cap’s investigational device exemption application to begin a pilot study of the company’s C-Scan system. 1. The conditional ...
ISFIYA, Israel, Sept. 4, 2018 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical-stage medical ...
Check-Cap (NASDAQ:CHEK) and GE Healthcare has completed manufacturing line transfer implementation and qualification for the C-Scan System. This collaboration was primarily initiated to enable the ...
ISFIYA, Israel, Aug. 19, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the ...
Check-Cap Ltd. is reporting positive results from a pilot study of its C-Scan System. The Isfiya, Israel-based company’s C-Scan System is a preparation-free ingestible scanning capsule-based system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results